CTI BioPharma Presents Data from Pacritinib Program at the 63rd American Society of Hematology MeetingPRNewsWire • 12/13/21
5 White-Hot Stocks Trading Under $10 to Buy Now Have Great Upside Potential24/7 Wall Street • 12/04/21
CTI BioPharma to Present at the JMP Securities Hematology & Oncology Summit on Monday, December 6PRNewsWire • 12/02/21
CTI BioPharma Announces Extension of FDA Review Period for Pacritinib in Myelofibrosis with Severe ThrombocytopeniaPRNewsWire • 11/30/21
Implied Volatility Surging for CTI BioPharma (CTIC) Stock OptionsZacks Investment Research • 11/26/21
CTI BioPharma Announces Presentations at the 63rd American Society of Hematology MeetingPRNewsWire • 11/04/21
CTI BioPharma Announces Topline Data from Final Analysis of the PRE-VENT Clinical Trial Evaluating Pacritinib as a Treatment for Severe COVID-19PRNewsWire • 10/01/21
CTI BioPharma and DRI Healthcare Trust Announce up to $135 Million Debt and Royalty TransactionPRNewsWire • 08/25/21
CTI BioPharma Corp. (CTIC) CEO Adam Craig on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/06/21